<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1079">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05147103</url>
  </required_header>
  <id_info>
    <org_study_id>21-892</org_study_id>
    <nct_id>NCT05147103</nct_id>
  </id_info>
  <brief_title>Investigation of the Duration of Low-intensity Focused Ultrasound</brief_title>
  <official_title>Investigation of the Duration of Low-intensity Focused Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Polytechnic Institute and State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Polytechnic Institute and State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project examines the effects of various durations of noninvasive neuromodulation on&#xD;
      muscle contractions. The investigators believe this study will help to better understand&#xD;
      noninvasive brain stimulation techniques that may have the potential to aid in addiction,&#xD;
      pain, and mental health issues. Participants undergo structural imaging, a functional&#xD;
      Magnetic Resonance Image (fMRI) and computed tomography (CT). These images are used to align&#xD;
      the low-intensity focused ultrasound (LIFU) and transcranial magnetic stimulation (TMS)&#xD;
      devices to temporarily change brain activity. Electromyography (EMG) will be used to record&#xD;
      muscle contractions of the hand.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Multi-visit study, testing various LIFU durations</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Waveforms</measure>
    <time_frame>Outcomes assessed throughout participation - an average of 3 weeks.</time_frame>
    <description>Changes in waveform peak will be observed per each variable application of LIFU</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Development of LIFU for Clinical Purposes</condition>
  <arm_group>
    <arm_group_label>Duration Trials</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six different durations (three intermittent and three continuous) of LIFU application will be tested across six study sessions. Response recorded using TMS and EMG.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low-Intensity Focused Ultrasound</intervention_name>
    <description>LIFU application using various durations, responses of neuromodulation recorded using TMS and EMG.</description>
    <arm_group_label>Duration Trials</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Above criteria and must understand and speak English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to MRI, CT, or TMS&#xD;
&#xD;
               1. Claustrophobia&#xD;
&#xD;
               2. Pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes,&#xD;
                  steel worker, or other implants.&#xD;
&#xD;
               3. Pregnancy&#xD;
&#xD;
               4. Active medical disorder or treatment with potential CNS effects&#xD;
&#xD;
               5. History of neurologic disorder&#xD;
&#xD;
               6. History of head injury resulting in loss of consciousness for &gt;10 minutes&#xD;
&#xD;
               7. History of alcohol or drug dependence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wynn Legon, PhD</last_name>
    <phone>540-526-2184</phone>
    <email>wlegon@vtc.vt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica Florig, MPH</last_name>
    <phone>540-526-2375</phone>
    <email>jnw@vtc.vt.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Legon W, Bansal P, Tyshynsky R, Ai L, Mueller JK. Transcranial focused ultrasound neuromodulation of the human primary motor cortex. Sci Rep. 2018 Jul 3;8(1):10007. doi: 10.1038/s41598-018-28320-1.</citation>
    <PMID>29968768</PMID>
  </reference>
  <reference>
    <citation>Legon W, Ai L, Bansal P, Mueller JK. Neuromodulation with single-element transcranial focused ultrasound in human thalamus. Hum Brain Mapp. 2018 May;39(5):1995-2006. doi: 10.1002/hbm.23981. Epub 2018 Jan 29.</citation>
    <PMID>29380485</PMID>
  </reference>
  <reference>
    <citation>Legon W, Sato TF, Opitz A, Mueller J, Barbour A, Williams A, Tyler WJ. Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans. Nat Neurosci. 2014 Feb;17(2):322-9. doi: 10.1038/nn.3620. Epub 2014 Jan 12.</citation>
    <PMID>24413698</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 10, 2021</study_first_submitted>
  <study_first_submitted_qc>December 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2021</study_first_posted>
  <last_update_submitted>December 6, 2021</last_update_submitted>
  <last_update_submitted_qc>December 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Virginia Polytechnic Institute and State University</investigator_affiliation>
    <investigator_full_name>Wynn Legon</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>low-intensity focused ultrasound</keyword>
  <keyword>transcranial magnetic stimulation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

